Lexicon Pharmaceuticals: Q4 Earnings Insights

Lexicon Pharmaceuticals LXRX reported its Q4 earnings results on Monday, March 11, 2024 at 07:15 AM.

Here's what investors need to know about the announcement.

Earnings

Lexicon Pharmaceuticals beat estimated earnings by 9.0%, reporting an EPS of $-0.2 versus an estimate of $-0.22.

Revenue was up $674 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 9.0% drop in the share price the next day.

Here's a look at Lexicon Pharmaceuticals's past performance:

To track all earnings releases for Lexicon Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.